Cannabis companies on the move


DirectView Holdings (DIRV) will open a Colorado office in April to support its cannabis industry security and surveillance business.

Growlife (PHOT) extends its due diligence completion date to April 4 regarding its technology distribution deal with RXNB.

Nuvilex (NVLX) contracts with Austrianova Singapore to perform cGMP-compliant encapsulation of live cells for its inoperable pancreatic cancer clinical trials.

IMD Companies (ICBU) implements a network interface into its environmental controller to allow remote grow room monitoring.

Supreme Pharmaceuticals (SPRWF) signs a 12-month purchase option agreement for a medical marijuana producer for $1M.

Comments (4)
  • Badstory
    , contributor
    Comments (36) | Send Message
     
    NVLX seems to be the top of thetop when it comes to medicinal MJ. Dr Mark rabe will be presenting : SILVER SPRING, Md. , March 25, 2014 (GLOBE NEWSWIRE) -- Nuvilex, Inc. (OTCQB:NVLX), a clinical-stage international biotechnology company providing cell and gene therapy solutions for the treatment of diseases, announced today that holistic and medical marijuana expert Dr. Mark L. Rabe , Chairman of the Scientific Advisory Board of Nuvilex's subsidiary, Medical Marijuana Sciences, Inc. , will deliver a significant presentation at the 2nd Annual National Medical Cannabis Unity Conference "Navigating Medical Cannabis in the Mainstream" that will be held in Washington, DC April 5-7, 2014 . Dr. Rabe's presentation will take place at the Mayflower Hotel on April 6 .
    Dr. Rabe will review the history of the use of marijuana and its constituents for medicinal purposes and discuss the constituents of the marijuana plant, known as cannabinoids, which have historically shown biological activity, with particular emphasis on their use in treating serious and deadly diseases. Most importantly, Dr. Rabe will speak to the potential use of cannabinoids in combination with the proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box® in developing treatments for pancreatic and brain cancer, two of the deadliest forms of that disease. Cell-in-a-Box®, in combination with the anticancer drug ifosfamide, was proven effective in early-stage clinical trials and is currently being prepared for late-stage clinical trials by Nuvilex for the treatment of advanced, inoperable pancreatic cancer.
    The National Medical Cannabis Unity Conference is sponsored by Americans for Safe Access (ASA). The goals of the ASA are to ensure safe and legal access to marijuana (cannabis) for therapeutic uses and research. The Conference will allow patients, medical practitioners and advocates of medical marijuana to interact, exchange ideas and discuss the navigation of medical marijuana in today's political landscape.
    Kenneth L. Waggoner , CEO and President of Nuvilex , commented, "The presentation by Dr. Rabe at this important conference will help showcase Medical Marijuana Sciences and its efforts to develop cannabis-based cancer treatments to a diverse community of those with a genuine interest in developing constituents of marijuana for medical treatment of serious diseases and their associated symptoms. It is our hope that, through events such as the National Medical Cannabis Unity Conference , the usefulness of constituents of cannabis for serious and deadly diseases can ultimately be fully realized."
    25 Mar 2014, 12:33 PM Reply Like
  • urbangreen
    , contributor
    Comments (3) | Send Message
     
    Thank you
    26 Mar 2014, 09:11 AM Reply Like
  • cbo2007@aol.com
    , contributor
    Comments (316) | Send Message
     
    I have done a lot of research on icbu and can't find anything worth anything. They say the famous Izzy Zalcberg invested a million bucks, with more if needed. Well that's interesting, because I found another article where he invested over a million bucks in CYBK on Feb. 12th. If you read the article, it's almost word for word the same article. Is ICBU making this up? I think so. If you go to their site all the say is they are looking for investments in the medical marijuana business and all their other so called investments, if you go to those websites they refer you back to ICBU's web site. ICBU to me is a shell hiding behind other shell companies and will say anything to get a boost in their stock. But in reality they are probably the only ones laughing all the way to the bank. Stay away from ICBU. Does anybody know if what their doing is even legal? I don't. I haven't invested any money in this company and won't, but my brother has. That's why I checked them out. And one more thing, they have filed nothing with sec.gov and mentions nothing about any real income anywhere.
    26 Mar 2014, 09:12 AM Reply Like
  • User 24678603
    , contributor
    Comments (6) | Send Message
     
    NVLX is more then a cannabis stock...

     

    Must read!

     

    http://yhoo.it/1jFg5Fo
    10 Apr 2014, 04:26 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs